Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nevro Corp (NVRO)

Nevro Corp (NVRO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Nevro Announces the Full Exercise of the Underwriter's Option to Purchase Additional Common Stock and the Underwriter's Over-allotment Option to Purchase Additional Convertible Senior Notes

Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that the underwriter of each...

NVRO : 93.96 (-1.38%)
Nevro Corp Set to Possibly Rebound After Yesterday's Selloff of 3.67%

Nevro Corp (NYSE:NVRO) traded in a range yesterday that spanned from a low of $90.82 to a high of $95.35. Yesterday, the shares fell 3.7%, which took the trading range below the 3-day low of $97.24 on...

NVRO : 93.96 (-1.38%)
Nevro (NVRO) Looks Good: Stock Adds 6.5% in Session

Nevro (NVRO) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

MASI : 182.12 (-0.92%)
NVRO : 93.96 (-1.38%)
Walgreens, Shopify fall; Occidental, Nevro rise

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Thursday:

MTN : 131.73 (-5.48%)
OXY : 13.00 (+1.80%)
NVRO : 93.96 (-1.38%)
CHS : 0.9606 (-4.89%)
SHOP.TO : 504.52 (+2.29%)
PVH : 30.99 (-2.76%)
Nevro Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the pricing of concurrent underwritten...

NVRO : 93.96 (-1.38%)
Nevro Announces Proposed Public Offering of Common Stock and Convertible Senior Notes

Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has commenced a proposed...

NVRO : 93.96 (-1.38%)
Nevro Provides First Quarter and FY2020 Update

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced preliminary unaudited worldwide revenue...

NVRO : 93.96 (-1.38%)
Why Is Nevro (NVRO) Down 34.3% Since Last Earnings Report?

Nevro (NVRO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NVRO : 93.96 (-1.38%)
Watch for Nevro Corp to Potentially Rebound After Falling 4.61% Yesterday

Nevro Corp (NYSE:NVRO) traded in a range yesterday that spanned from a low of $94.29 to a high of $104.97. Yesterday, the shares fell 4.6%, which took the trading range below the 3-day low of $95.03...

NVRO : 93.96 (-1.38%)
Nevro (NVRO): Strong Industry, Solid Earnings Estimate Revisions

Nevro (NVRO) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

NVRO : 93.96 (-1.38%)
Nevro and Stimwave Reach Worldwide Settlement in Patent Infringement Lawsuit: Stimwave Agrees to a Permanent Injunction

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced the settlement of its patent infringement...

NVRO : 93.96 (-1.38%)
Nevro Files Lawsuit for Patent Infringement Against Nalu Medical in the U.S.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that it has filed a lawsuit for patent...

NVRO : 93.96 (-1.38%)
Nevro (NVRO) Q4 Loss Narrower Than Expected, Revenues Up Y/Y

Nevro (NVRO) sees strong segmental contributions in Q4.

SYK : 148.07 (-1.01%)
ARAY : 1.7300 (+1.17%)
IDXX : 234.55 (-2.15%)
NVRO : 93.96 (-1.38%)
Nevro (NVRO) Reports Q4 Loss, Tops Revenue Estimates

Nevro (NVRO) delivered earnings and revenue surprises of 29.03% and 3.20%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

NVRO : 93.96 (-1.38%)
Nevro: 4Q Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Nevro Corp. (NVRO) on Tuesday reported a loss of $13.7 million in its fourth quarter.

NVRO : 93.96 (-1.38%)
What in Store for Universal Health's (UHS) Q4 Earnings?

Universal Health's (UHS) Q4 results are likely to reflect gains from both its Acute Care and Behavioral Health segments.

UHS : 85.38 (-3.75%)
AMAG : 6.14 (+0.99%)
ADRO : 2.54 (+1.20%)
NVRO : 93.96 (-1.38%)
What's in Store for Patterson Companies' (PDCO) Q3 Earnings?

Patterson Companies (PDCO) expects Animal Health sales to have been soft in fiscal Q3.

ABM : 22.78 (-6.02%)
PDCO : 13.47 (-6.20%)
BURL : 140.56 (-3.36%)
NVRO : 93.96 (-1.38%)
Why Earnings Season Could Be Great for Nevro (NVRO)

Nevro (NVRO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

NVRO : 93.96 (-1.38%)
What's in Store for Fulgent Genetics (FLGT) Q4 Earnings?

Fulgent Genetics' (FLGT) fourth-quarter 2019 earnings are likely to reflect top-line growth and elevated test volumes.

BAX : 81.42 (-0.97%)
HQY : 41.09 (-6.38%)
NVRO : 93.96 (-1.38%)
FLGT : 9.54 (-4.89%)
What's in Store for Tenet Healthcare's (THC) Q4 Earnings?

Tenet Healthcare's (THC) Q4 results are likely to reflect higher revenues, aided by its Hospital and Other Operations as well as Ambulatory segments, partly offset by lower admissions.

THC : 11.89 (-9.86%)
ADPT : 25.72 (-8.57%)
ADRO : 2.54 (+1.20%)
NVRO : 93.96 (-1.38%)

Van Meerten Stock Picks

My 5 Favorite Mid Caps
Summary 100% technical buy signals with current momentum.
CRUS -2.23 , SEDG -2.49 , THC -1.30 , TER -0.57 , LITE -3.30
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar